Literature DB >> 12364356

AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade.

Robert E Widdop1, Khalid Matrougui, Bernard I Levy, Daniel Henrion.   

Abstract

Angiotensin II type 2 receptor (AT2R) stimulation may cause vasodilation per se and may contribute to the antihypertensive effect produced by Angiotensin II type 1 receptor (AT1R) antagonists, given that AT1R blockade increases endogenous levels of Ang II, suggesting a physiological role for the unblocked AT2R. Thus, we first directly assessed whether or not there is desensitization to AT2R-mediated vasorelaxation because this is an important consideration, given the raised Ang II levels and the marked desensitization that is known to occur after AT1R stimulation. Second, we examined if AT2R-mediated vasorelaxation is preserved after long-term treatment with the AT1R antagonist candesartan cilexetil. Consecutive concentration-response curves to AT2R stimulation, with either Ang II (with AT1R blockade) or the selective agonist CGP42112, were studied in rat isolated mesenteric resistance arteries mounted in an arteriograph. AT2R stimulation with Ang II induced a concentration-dependent relaxation without desensitization. Similarly, CGP42112 evoked highly reproducible relaxation, which, like Ang II, was abolished by the AT2R antagonist PD123319. By contrast, AT1R-mediated contraction exhibited marked desensitization. In rats treated with candesartan cilexetil (2 mg/kg per day for 2 weeks), AT1R-mediated contraction was abolished, whereas AT2R-mediated relaxation evoked by either Ang II or CGP42112 was highly reproducible, PD123319-sensitive, and of a magnitude similar to that observed in naïve animals. Therefore, this study has provided unequivocal evidence for the reproducible nature of AT2R-mediated vasorelaxation during short-term and long-term AT1R blockade. Such preservation of AT2R function is a prerequisite for the consideration of physiological role(s) of AT2R during AT1R blockade.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364356     DOI: 10.1161/01.hyp.0000033224.99806.8a

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

Review 1.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

2.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

3.  High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.

Authors:  Dong You; Laurent Loufrani; Celine Baron; Bernard I Levy; Robert E Widdop; Daniel Henrion
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

Review 4.  The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.

Authors:  Helmy M Siragy
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

5.  Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo.

Authors:  Amanda K Sampson; Jennifer C Irvine; Waled A Shihata; Dragana Dragoljevic; Natalie Lumsden; Olivier Huet; Tyrone Barnes; Thomas Unger; Ulrike M Steckelings; Garry L Jennings; Robert E Widdop; Jaye P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2015-06-29       Impact factor: 8.739

Review 6.  Understanding the Two Faces of Low-Salt Intake.

Authors:  Branko Braam; Xiaohua Huang; William A Cupples; Shereen M Hamza
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 7.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

Review 8.  Update on the angiotensin AT(2) receptor.

Authors:  Claudia A McCarthy; Robert E Widdop; Kate M Denton; Emma S Jones
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

9.  Long-term treatment of spontaneously hypertensive rats with PD123319 and electrophysiological remodeling of left ventricular myocardium.

Authors:  Xiao Ying; Guan Kai-Pan; Long Wei-Qing; Peng Long-Yun; Wu De-Xi; Huang Zhi-Bin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-14       Impact factor: 3.000

Review 10.  Vasodilator factors in the systemic and local adaptations to pregnancy.

Authors:  Gloria Valdes; Peter Kaufmann; Jenny Corthorn; Rafaela Erices; K Bridget Brosnihan; Janae Joyner-Grantham
Journal:  Reprod Biol Endocrinol       Date:  2009-07-31       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.